R H Grose1, A G Cummins, F M Thompson. 1. Department of Gastroenterology and Hepatology, The Queen Elizabeth Hospital, Woodville Road, Woodville South, 5011, South Australia, Australia.
Abstract
BACKGROUND: Immunoregulatory invariant natural killer (iNK) T cells rapidly produce interleukin (IL)-4 and other cytokines that suppress a Th1 response and are deficient in some autoimmune diseases. AIM: The aim of this study was to investigate any deficiency of iNK T cells in coeliac disease. METHODS: Blood was collected from 86 subjects with coeliac disease and from 152 healthy control subjects for investigation of Valpha24+ T cells by flow cytometry. iNK T cells were assessed by Valpha24 and alpha-galactosylceramide/CD1d tetramer markers in 23 normal controls and 13 subjects with coeliac disease. Intracellular IL-4 was measured after anti-CD3 antibody stimulation. Duodenal biopsies were obtained in a subgroup of subjects with coeliac disease and control subjects for Valpha24 mRNA expression using relative PCR and for Valpha24+ T cells by immunofluorescence. RESULTS: The mean numbers of circulating Valpha24+ T cells and iNK T cells in coeliac disease were 27% (p<0.001) and 16% (p<0.001), respectively, of levels in control subjects. After in vitro anti-CD3 stimulation, numbers of IL-4+ producing iNK T cells from subjects with coeliac disease were unchanged but increased by 21% in control subjects. In subjects with coeliac disease, Valpha24 mRNA intestinal expression was reduced to 17% (p<0.001) by relative PCR and numbers of intestinal Valpha24+ T cells were 16% (p<0.01) of levels in control subjects. CONCLUSIONS: We conclude that Valpha24+ T cells and iNK T cells are deficient in coeliac disease. We speculate that this deficiency could contribute to the failure of immunological oral tolerance that seems to underlie this disease.
BACKGROUND: Immunoregulatory invariant natural killer (iNK) T cells rapidly produce interleukin (IL)-4 and other cytokines that suppress a Th1 response and are deficient in some autoimmune diseases. AIM: The aim of this study was to investigate any deficiency of iNK T cells in coeliac disease. METHODS: Blood was collected from 86 subjects with coeliac disease and from 152 healthy control subjects for investigation of Valpha24+ T cells by flow cytometry. iNK T cells were assessed by Valpha24 and alpha-galactosylceramide/CD1d tetramer markers in 23 normal controls and 13 subjects with coeliac disease. Intracellular IL-4 was measured after anti-CD3 antibody stimulation. Duodenal biopsies were obtained in a subgroup of subjects with coeliac disease and control subjects for Valpha24 mRNA expression using relative PCR and for Valpha24+ T cells by immunofluorescence. RESULTS: The mean numbers of circulating Valpha24+ T cells and iNK T cells in coeliac disease were 27% (p<0.001) and 16% (p<0.001), respectively, of levels in control subjects. After in vitro anti-CD3 stimulation, numbers of IL-4+ producing iNK T cells from subjects with coeliac disease were unchanged but increased by 21% in control subjects. In subjects with coeliac disease, Valpha24 mRNA intestinal expression was reduced to 17% (p<0.001) by relative PCR and numbers of intestinal Valpha24+ T cells were 16% (p<0.01) of levels in control subjects. CONCLUSIONS: We conclude that Valpha24+ T cells and iNK T cells are deficient in coeliac disease. We speculate that this deficiency could contribute to the failure of immunological oral tolerance that seems to underlie this disease.
Authors: T Sumida; A Sakamoto; H Murata; Y Makino; H Takahashi; S Yoshida; K Nishioka; I Iwamoto; M Taniguchi Journal: J Exp Med Date: 1995-10-01 Impact factor: 14.307
Authors: K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid Journal: J Exp Med Date: 1993-07-01 Impact factor: 14.307
Authors: Sara Calleja; Santiago Vivas; María Santiuste; Laura Arias; Mercedes Hernando; Esther Nistal; Javier Casqueiro; Jose G Ruiz de Morales Journal: Dig Dis Sci Date: 2011-01-08 Impact factor: 3.199
Authors: M Uhde; X Yu; A Bunin; C Brauner; S K Lewis; B Lebwohl; S Krishnareddy; A Alaedini; B Reizis; S Ghosh; P H Green; G Bhagat Journal: Clin Exp Immunol Date: 2020-01-27 Impact factor: 4.330
Authors: Margaret R Dunne; Louise Elliott; Seamus Hussey; Nasir Mahmud; Jacinta Kelly; Derek G Doherty; Conleth F Feighery Journal: PLoS One Date: 2013-10-04 Impact factor: 3.240
Authors: Alexandra Lind; Peter D Siersema; Johannes G Kusters; Jan A M Van der Linden; Edward F Knol; Leo Koenderman Journal: PLoS One Date: 2012-04-03 Impact factor: 3.240
Authors: Jin S Im; Tae-Jin Kang; Seong-Beom Lee; Chi-Hong Kim; Sang-Haak Lee; Manjunatha M Venkataswamy; Evan R Serfass; Bing Chen; Petr A Illarionov; Gurdyal S Besra; William R Jacobs; Gue-Tae Chae; Steven A Porcelli Journal: Clin Immunol Date: 2008-03-04 Impact factor: 3.969
Authors: Enrique Montalvillo; David Bernardo; Beatriz Martínez-Abad; Yessica Allegretti; Luis Fernández-Salazar; Carmen Calvo; Fernando G Chirdo; José A Garrote; Eduardo Arranz Journal: Nutrients Date: 2015-10-30 Impact factor: 5.717